SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 61 filers reported holding SYNERON MEDICAL LTD in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $38,000 | -90.6% | 3,476 | -91.0% | 0.00% | -100.0% |
| Q1 2017 | $406,000 | -2.9% | 38,476 | -22.7% | 0.00% | -33.3% |
| Q4 2016 | $418,000 | +1717.4% | 49,800 | +1456.2% | 0.00% | – |
| Q3 2016 | $23,000 | -4.2% | 3,200 | +3.2% | 0.00% | – |
| Q2 2016 | $24,000 | +4.3% | 3,100 | 0.0% | 0.00% | – |
| Q1 2016 | $23,000 | -50.0% | 3,100 | -48.0% | 0.00% | – |
| Q4 2015 | $46,000 | -73.6% | 5,959 | -75.5% | 0.00% | -100.0% |
| Q3 2015 | $174,000 | +3380.0% | 24,300 | +5975.0% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 400 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | -95.1% | 400 | -95.1% | 0.00% | -100.0% |
| Q3 2014 | $81,000 | +8000.0% | 8,100 | +8000.0% | 0.00% | – |
| Q2 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | -50.0% | 100 | -50.0% | 0.00% | – |
| Q3 2013 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 706,107 | $5,931,000 | 5.46% |
| NORTH TIDE CAPITAL, LLC | 3,500,000 | $29,400,000 | 5.03% |
| Senvest Management, LLC | 3,777,775 | $31,733,000 | 2.26% |
| Kenmare Capital Partners, L.L.C. | 269,839 | $2,267,000 | 1.72% |
| Camber Capital Management LP | 2,347,593 | $19,720,000 | 1.03% |
| DALTON GREINER HARTMAN MAHER & CO | 1,785,826 | $15,001,000 | 0.88% |
| PERRITT CAPITAL MANAGEMENT INC | 425,170 | $3,571,000 | 0.87% |
| Profit Investment Management, LLC | 88,777 | $746,000 | 0.70% |
| DAFNA Capital Management LLC | 85,947 | $722,000 | 0.63% |
| Lapides Asset Management, LLC | 396,800 | $3,333,000 | 0.60% |